Drug Trial Radar · NCT03066947
SV-BR-1-GM in Metastatic or Locally Recurrent Breast Cancer
Last checked: Nov 20, 2026Latest source record: Jan 29, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
24
Actual
Start
May 5, 2017
Primary completion
Nov 22, 2018
Study completion Nov 22, 2018
Sponsor
- Lead sponsor
- BriaCell Therapeutics CorporationIndustry
- Sponsor type
- Industry
- Collaborators
- Cancer Insight, LLC
- First posted
- Mar 1, 2017
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a single arm, open label study of SV-BR-1-GM, a targeted immunotherapy for breast cancer. Eligible patients will have histological confirmation of breast cancer with recurrent and/or metastatic lesions. The treatment regimen includes a pre-treatment with low-dose cyclophosphamide 2-3 days before the inoculation; inoculation in 4 sites on the thighs and upper back; and post-treatment inoculation of Interferon-alpha-2b into the sites of inoculation \~2 and \~4 days after the inoculation. These is repeated every 2 weeks for one month (3 treatments), then monthly for up to one year. Standard tumor assessments are performed at baseline and then every 2-3 months.
Conditions
- Breastcancer
- Breast Neoplasm
Interventions
SV-BR-1-GMBiological
See above
CyclophosphamideDrug
Low dose pre-treatment to reduce regulatory T cells
Interferon-alpha-2bBiological
Low dose given in the vaccine site to boost the immune response
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Patients With Treatment Emergent Adverse Events Occurring in Two or More Patients [Safety]Time frame: Through study completion, an average of 1 year
Locations
5 sites in 1 country. Site status is shown where the registry gives one.
St. Joseph Heritage Healthcare
Santa Rosa, California
University of Miami/Sylvester at Plantation
Plantation, Florida
Cancer Center of Kansas (CCK)
Wichita, Kansas
Thomas Jefferson University
Philadelphia, Pennsylvania
Providence Regional Medical Center
Everett, Washington
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.